These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Synthesis and properties of 2H-2-(4-substituted -1-piperazinylalkyl)-4,6-dimethyl-3-oxo-2,3-dihydroisothiazolo [5,4-b] pyridines. Malinka W Acta Pol Pharm; 1990; 47(1-2):51-6. PubMed ID: 12959260 [TBL] [Abstract][Full Text] [Related]
26. [Hypocholesteremic and hypolipemic effects of p-chlorophenoxy-alpha-isobutyrate of 3-hydroxymethylpyridine hydrochloride]. Marmo E; Imperatore AM; Caputi A; Cataldi S Farmaco Prat; 1971 Oct; 26(10):557-84. PubMed ID: 5157541 [No Abstract] [Full Text] [Related]
27. Amides of 1,3,3-trimethyl-n-[(2-pyridyl)methyl]-2-oxabicyclo [2.2.2]octan-6-amine with depressant and antiarrhythmic activities. Mariani E; Bondavalli F; Schenone P; Benincasa T; Vitagliano S; Marmo E Farmaco; 1989 May; 44(5):503-10. PubMed ID: 2789628 [TBL] [Abstract][Full Text] [Related]
28. Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts. Shudo N; Mizoguchi T; Kiyosue T; Arita M; Yoshimura A; Seto K; Sakoda R; Akiyama S Cancer Res; 1990 May; 50(10):3055-61. PubMed ID: 1970752 [TBL] [Abstract][Full Text] [Related]
29. Novel acyl-CoA:cholesterol acyltransferase inhibitors. Synthesis and biological activity of 3-quinolylurea derivatives. Tawada H; Harcourt M; Kawamura N; Kajino M; Ishikawa E; Sugiyama Y; Ikeda H; Meguro K J Med Chem; 1994 Jun; 37(13):2079-84. PubMed ID: 8027989 [TBL] [Abstract][Full Text] [Related]
30. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 3. Discovery of a novel series of N-alkyl-N-[(fluorophenoxy)benzyl]-N'-arylureas with weak toxicological effects on adrenal glands. Tanaka A; Terasawa T; Hagihara H; Ishibe N; Sawada M; Sakuma Y; Hashimoto M; Takasugi H; Tanaka H J Med Chem; 1998 Oct; 41(22):4408-20. PubMed ID: 9784116 [TBL] [Abstract][Full Text] [Related]
31. Morphological and enzymatic alterations in the rat liver caused by administration of a hypocholesterolemic agent AT-308 and its related compounds. Arakawa M; Miyajima H; Matsumura H; Izukawa M; Imai Y Biochem Pharmacol; 1978 Jan; 27(2):167-71. PubMed ID: 623672 [No Abstract] [Full Text] [Related]
32. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity. Trivedi BK; Purchase TS; Holmes A; Augelli-Szafran CE; Essenburg AD; Hamelehle KL; Stanfield RL; Bousley RF; Krause BR J Med Chem; 1994 May; 37(11):1652-9. PubMed ID: 8201599 [TBL] [Abstract][Full Text] [Related]
33. [CLINICAL EXPERIMENTATION ON THE HYPOCHOLESTEROLEMIZING ACTION OF THE N-OXIDE OF PYRIDINE-3-CARBOXYLIC ACID]. PADOLECCHIA N; PANARO A; FASANO V; ARMENIO L G Clin Med; 1963 Oct; 44():1015-27. PubMed ID: 14333662 [No Abstract] [Full Text] [Related]
34. Synthesis and anticonvulsant activity of 3-(3'-trifluoromethylphenoxy)-pyridines and -dihydropyridines. Phillips OA; Knaus EE Drug Des Deliv; 1991 Jul; 7(4):279-86. PubMed ID: 1657018 [TBL] [Abstract][Full Text] [Related]
35. N-phenylpiperazine derivatives with hypocholesterolemic activity. Cascio G; Manghisi E; Porta R; Fregnan G J Med Chem; 1985 Jun; 28(6):815-8. PubMed ID: 4009605 [TBL] [Abstract][Full Text] [Related]
36. [Protective measures taken in the industrial production of hypocholesteremic drugs, with an organic iodine base]. Gobbi A; Metrico L; Grisler R Med Lav; 1971 May; 62(5):272-6. PubMed ID: 5143199 [No Abstract] [Full Text] [Related]
37. Experiences with a hypocholesteremic agent as a dietary supplement. HIRSHLEIFER I Postgrad Med; 1960 Oct; 28():434-9. PubMed ID: 13714634 [No Abstract] [Full Text] [Related]
38. Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety. Thapa P; Karki R; Yun M; Kadayat TM; Lee E; Kwon HB; Na Y; Cho WJ; Kim ND; Jeong BS; Kwon Y; Lee ES Eur J Med Chem; 2012 Jun; 52():123-36. PubMed ID: 22503656 [TBL] [Abstract][Full Text] [Related]
39. 2-Substituted-3-pyridinolethers as hypolipidemic and platelet aggregation inhibiting agents. Desideri N; Manna F; Stein ML; Vairo G; Del Gaudio F; Gentile B; Marmo E Farmaco Sci; 1985 Sep; 40(9):630-44. PubMed ID: 3841074 [TBL] [Abstract][Full Text] [Related]
40. Time-dependent inhibition of rat brain monoamine oxidase by an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine. Arai Y; Hamamichi N; Kinemuchi H Neurosci Lett; 1986 Oct; 70(2):255-60. PubMed ID: 3490636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]